LAVA Therapeutics NV (LVTX) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.46
-0.35
-0.24
-0.13

Details

Expected EPS
-0.3675
Actual EPS
-0.13
Surprise EPS
0.24
Surprise Percent
+64.63%

Description

LAVA Therapeutics NV (LVTX) has reported earnings of -0.13 per share for Q2 2025.

0 Comments

Share your thoughts